Global Coronavirus Diagnostics Market

Global coronavirus diagnostics market was valued at USD73538.02 million in 2020 and the market is anticipated to reach USD15579.56 million by 2026. The main reason for the increase in the rate of coronavirus diagnostics market is because of the mass-scale testing to identify asymptomatic cases of COVID-19 infection. As of 18th January 2022, there were 328,532,929 confirmed cases of COVID-19, including 5,542,359 deaths, reported to WHO. Molecular testing in global coronavirus diagnostics market garnered 55.26% share in 2020E and is expected to continue its dominance during the forecast period. The molecular diagnostic assay has been introduced to detect SARS-CoV-2 RNA in respiratory specimens and is recommended for patients who meet the CDC’s clinical and epidemiologic criteria for COVID-19 testing, thereby, driving the growth of the global coronavirus diagnostics market.